Open Access

Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury

  • Authors:
    • Xiaoyue Zhang
    • Wenchao Hong
    • Na Li
    • Xiaohui Gong
    • Cheng Cai
  • View Affiliations

  • Published online on: October 26, 2022     https://doi.org/10.3892/etm.2022.11669
  • Article Number: 733
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To explore the optimal stage of initiating continuous renal replacement therapy (CRRT) in the treatment of neonatal acute kidney injury (AKI), a total of 25 AKI neonates treated with CRRT were hospitalized at the Department of Neonatology of Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University (Shanghai, China) from November 2016 to June 2021. According to the renal function, the AKI neonates prior to CRRT were divided into two groups as follows: AKI stage 0‑1 and AKI stage 2‑3. The changes noted in specific indicators including renal function, electrolyte concentration, and acid‑base balance index were analyzed at 0, 12, 24 and 48 h, and at the end of the CRRT treatment. Among the 25 neonates with AKI, serum potassium, urea nitrogen and creatinine levels were significantly decreased following 12 h of CRRT treatment and reached the normal range following 24 h of CRRT treatment with a significant increase in the volume of urine. The serum creatinine levels of the neonates in the AKI stage 0‑1 group were significantly decreased following 24 h of CRRT treatment and urine output was significantly increased. At 24 h and following CRRT treatment, the levels of serum creatinine of AKI stage 2‑3 neonates were higher than those of AKI stage 0‑1 neonates (F=3.013, 5.005; P<0.05), and at all time‑points, the urine output of AKI stage 0‑1 was higher than that of AKI stage 2‑3 (F=13.785, 4.008, 0.965; P<0.05). A total of four cases of thrombocytopenia, two cases of obstruction, and two cases of hypotension were noted in the course of CRRT treatment (the occurrence rate was 8/25). Therefore, it was concluded that CRRT could be an effective measure for the treatment of AKI neonates. Thus, ideally CRRT treatment of AKI neonates should be initiated in cases characterized as AKI stages 0‑1.
View Figures
View References

Related Articles

Journal Cover

December-2022
Volume 24 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Hong W, Li N, Gong X and Cai C: Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury. Exp Ther Med 24: 733, 2022
APA
Zhang, X., Hong, W., Li, N., Gong, X., & Cai, C. (2022). Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury. Experimental and Therapeutic Medicine, 24, 733. https://doi.org/10.3892/etm.2022.11669
MLA
Zhang, X., Hong, W., Li, N., Gong, X., Cai, C."Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury". Experimental and Therapeutic Medicine 24.6 (2022): 733.
Chicago
Zhang, X., Hong, W., Li, N., Gong, X., Cai, C."Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury". Experimental and Therapeutic Medicine 24, no. 6 (2022): 733. https://doi.org/10.3892/etm.2022.11669